Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al

被引:27
|
作者
Fabrizio, M. [1 ]
Gabriella, F. [1 ]
Nappa, P. [1 ]
Matteo, M. [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Dermatol Unit, Naples, Italy
关键词
EXACERBATION;
D O I
10.1111/jdv.18302
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E750 / E751
页数:2
相关论文
共 50 条
  • [1] Reply to 'development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani F et al
    Falcinelli, F.
    Lamberti, A.
    Cota, C.
    Rubegni, P.
    Cinotti, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (12) : E976 - E978
  • [2] Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2
    Solimani, F.
    Mansour, Y.
    Didona, D.
    Dilling, A.
    Ghoreschi, K.
    Meier, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E649 - E651
  • [3] Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2
    Nanova, Krassimira
    Zlotogorski, Abraham
    Ramot, Yuval
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : 1148 - 1149
  • [4] Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2
    Ramot, Yuval
    Nanova, Krassimira
    Faitatziadou, Sofia-Maria
    Abu Assab, Dania
    Berkun, Yackov
    Zlotogorski, Abraham
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (08):
  • [5] Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient
    Knechtl, G. V.
    Seyed Jafari, S. M.
    Berger, T.
    Rammlmair, A.
    Feldmeyer, L.
    Borradori, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (04) : E251 - E253
  • [6] Skin reaction following SARS-CoV-2 vaccine BNT162b2
    Russo, Filomena
    Santi, Francesco
    Sirchio, Azzurra
    Lazzeri, Laura
    De Piano, Ernesto
    Taddeucci, Paolo
    Rubegni, Pietro
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (04) : 360 - 361
  • [7] Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection
    Nemet, Ital
    Kliker, Limor
    Lustig, Yaniv
    Zuckerman, Neta
    Erster, Oran
    Cohen, Carmit
    Kreiss, Yitshak
    Alroy-Preis, Sharon
    Regev-Yochay, Gili
    Mendelson, Ella
    Mandelboim, Michal
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 492 - 494
  • [8] Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination
    Jongvilaikasem, Pondtip
    Rianthavorn, Pornpimol
    PEDIATRIC NEPHROLOGY, 2022, 37 (06) : 1419 - 1421
  • [9] Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination
    Gambichler, T.
    Scholl, L.
    Dickel, H.
    Ocker, L.
    Stranzenbach, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (07) : E415 - E416
  • [10] Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
    Steensels, Deborah
    Pierlet, Noella
    Penders, Joris
    Mesotten, Dieter
    Heylen, Line
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1533 - 1535